Omaha Public Schools | |
4261 N 142nd St, Omaha, NE 68164-5036 | |
(402) 490-9510 | |
Not Available |
Full Name | Omaha Public Schools |
---|---|
Type | Facility |
Speciality | Speech-language Pathologist |
Location | 4261 N 142nd St, Omaha, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033575477 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 505 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Omaha Public Schools 4261 N 142nd St, Omaha, NE 68164-5036 Ph: (402) 490-9510 | Omaha Public Schools 4261 N 142nd St, Omaha, NE 68164-5036 Ph: (402) 490-9510 |
News Archive
Disease is a private matter to many of us. For many reasons, we want to keep it to ourselves, and no cluster of disorders challenges patients' need for privacy more than inflammatory bowel disease.
Melanoma is a particularly difficult cancer to treat once it has metastasized, spreading throughout the body. University of Illinois researchers are using chemistry to find the deadly, elusive malignant cells within a melanoma tumor that hold the potential to spread.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma.
› Verified 8 days ago
Ms. Lesley Denise Larive, SPEECH LANGUAGE PATH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5116 N 176th St, Omaha, NE 68116 Phone: 402-415-1682 | |
William K Phillips, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2211 S 64th Plz Apt 434, Omaha, NE 68106 Phone: 206-660-7086 | |
Miss Kaitlyn Lee Cross, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11808 Grant St Fl 100, Omaha, NE 68164 Phone: 405-334-1375 | |
Amy Noel Richardson, MS CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8011 Chicago St, Omaha, NE 68114 Phone: 402-659-4991 Fax: 402-933-6345 | |
Sarah Mytty, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 8031 W Center Rd Ste 300, Omaha, NE 68124 Phone: 402-391-5002 | |
Rachel Lynn Nagawiecki, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 444 S 44th St, Omaha, NE 68131 Phone: 402-559-6460 Fax: 402-559-5737 | |
Randi Elizabeth Grace Westberry, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 555 N 30th St, Omaha, NE 68131 Phone: 531-355-5033 Fax: 531-355-5028 |